Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico C Beasley

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Microbiology|April 30, 2009
Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureusFederico C Beasley, Enrique D Vinés, Jason C Grigg, et al.
Plos Neglected Tropical Diseases|February 4, 2017
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisMelissa S Love, Federico C Beasley, Rajiv S Jumani, et al.
Journal of Innate Immunity|February 1, 2014
A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signalingFatemeh Askarian, Nina M van Sorge, Maria Sangvik, et al.
The Journal of Biological Chemistry|January 17, 2013
Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess developmentNina M van Sorge, Federico C Beasley, Ivan Gusarov, et al.
Chemistry & Biology|June 20, 2015
Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureusJeffrey K Holden, Soosung Kang, Federico C Beasley, et al.
Infection and Immunity|January 27, 2010
Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumoniaVictor J Torres, Ahmed S Attia, William J Mason, et al.
Scientific Reports|November 17, 2023
Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disordersGeza Ambrus-Aikelin, Katsuyuki Takeda, Anthony Joetham, et al.
Scientific Reports|August 19, 2023
JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disordersGeza Ambrus-Aikelin, Katsuyuki Takeda, Anthony Joetham, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Microbiology|April 30, 2009
Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureusFederico C Beasley, Enrique D Vinés, Jason C Grigg, et al.
Plos Neglected Tropical Diseases|February 4, 2017
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisMelissa S Love, Federico C Beasley, Rajiv S Jumani, et al.
Journal of Innate Immunity|February 1, 2014
A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signalingFatemeh Askarian, Nina M van Sorge, Maria Sangvik, et al.
The Journal of Biological Chemistry|January 17, 2013
Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess developmentNina M van Sorge, Federico C Beasley, Ivan Gusarov, et al.
Chemistry & Biology|June 20, 2015
Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureusJeffrey K Holden, Soosung Kang, Federico C Beasley, et al.
Infection and Immunity|January 27, 2010
Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumoniaVictor J Torres, Ahmed S Attia, William J Mason, et al.
Scientific Reports|November 17, 2023
Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disordersGeza Ambrus-Aikelin, Katsuyuki Takeda, Anthony Joetham, et al.
Scientific Reports|August 19, 2023
JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disordersGeza Ambrus-Aikelin, Katsuyuki Takeda, Anthony Joetham, et al.
Pageof 2